Abstract
Methyl inosine monophosphate (MIMP) augments preferentially the in vitro responses of human and murine lymphocytes to a T-cell mitogen such as phytohemagglutinin (PHA) and inconsistently to a B-cell mitogen such as pokeweed or lipopolysaccharide (LPS). In a normal interleukin-2-dependent cell line (CTLL), MIMP showed little or no effect on IL-2 action; however, in a murine CTLL line exhibiting impaired responses to IL-2, MIMP stimulated thymidine incorporation and restored the response to IL-2. MIMP augments the PHA responses of both CD4+ and CD8+ human peripheral blood T-cells. The effect of MIMP to augment the PHA response of human lymphocytes is paralleled by the parent molecule, IMP. MIMP, but not IMP, is resistant to hydrolysis by 5'nucleotidase; thus, MIMP appears to be a protected analogue of IMP which is capable of in vivo action. MIMP (100 micrograms/ml) augments the PHA responses of 15 to 24 elderly humans. MIMP also augments the PHA responses of eight HIV-infected pre-AIDS patients but not of eight AIDS patients. When PHA responses of human lymphocytes are suppressed in vitro by an HIV-derived immunosuppressive peptide, interferon alpha, or prostaglandin PGE2, MIMP (0.1-100 micrograms/ml) progressively restores the d...Continue Reading
References
Oct 1, 1992·International Journal of Immunopharmacology·M SosaJ W Hadden
May 1, 1992·International Journal of Immunopharmacology·J W HaddenE M Hadden
Jan 1, 1991·International Journal of Immunopharmacology·R A GoodN K Day
Mar 1, 1991·Trends in Pharmacological Sciences·J W Hadden
Jan 1, 1990·Cancer Immunology, Immunotherapy : CII·M Nelson, D Nelson
Dec 1, 1989·Immunological Reviews·P ScottA Sher
Nov 1, 1986·Reviews of Infectious Diseases·B T Rouse, D W Horohov
Jan 1, 1985·Springer Seminars in Immunopathology·S Specter, J W Hadden
Nov 1, 1984·Cellular Immunology·J Kaminkova, C F Lange
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·S HaraguchiN K Day
Sep 1, 1994·International Journal of Immunopharmacology·J W Hadden
Dec 1, 1994·Immunology Today·M Clerici, G M Shearer
Jun 1, 1993·Immunology Today·J W Hadden
Citations
May 1, 1992·International Journal of Immunopharmacology·J W HaddenE M Hadden
Jul 16, 2003·International Immunopharmacology·Kathy L Signorelli, John W Hadden
Jul 16, 2003·International Immunopharmacology·Paul H Naylor, John W Hadden
Aug 30, 2008·Medical Hypotheses·Max Jellinek
Sep 17, 2005·International Journal of Immunopathology and Pharmacology·S MarinovaM Vretenarska